Published in Vaccine Weekly, December 27th, 2000
Researchers from Italy and Merck Research Labs reported their results in the December 2000 issue of the Journal of Virology ("Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer," J Virol, 2000;74:11598-11607).
In the study, the researchers tested an experimental DNA-based vaccine against hepatitis C. They injected mice, rats, and rabbits with fragments of DNA from the hepatitis virus intended to elicit immunity. Some of the animals then received...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly